Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
ARIAD Pharmaceuticals
Scientific Title
Brigatinib in Patients With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib